0001209191-19-047446.txt : 20190826
0001209191-19-047446.hdr.sgml : 20190826
20190826193347
ACCESSION NUMBER: 0001209191-19-047446
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190822
FILED AS OF DATE: 20190826
DATE AS OF CHANGE: 20190826
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chung Christine
CENTRAL INDEX KEY: 0001775295
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36740
FILM NUMBER: 191054063
MAIL ADDRESS:
STREET 1: C/O FIBROGEN, INC.
STREET 2: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FIBROGEN INC
CENTRAL INDEX KEY: 0000921299
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-978-1200
MAIL ADDRESS:
STREET 1: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-08-22
0
0000921299
FIBROGEN INC
FGEN
0001775295
Chung Christine
C/O FIBROGEN, INC.
409 ILLINOIS ST.
SAN FRANCISCO
CA
94158
0
1
0
0
SVP, China Operations
Common Stock
2019-08-22
4
M
0
5625
19.39
A
157195
D
Common Stock
2019-08-22
4
S
0
5325
43.79
D
151870
D
Common Stock
2019-08-22
4
S
0
300
44.67
D
151570
D
Common Stock
2019-08-23
4
M
0
5625
19.39
A
157195
D
Common Stock
2019-08-23
4
S
0
3225
42.05
D
153970
D
Common Stock
2019-08-23
4
S
0
1816
42.94
D
152154
D
Common Stock
2019-08-23
4
S
0
584
43.68
D
151570
D
Stock Option (Right to Buy)
19.39
2019-08-22
4
M
0
5625
0.00
D
2026-02-22
Common Stock
5625
58579
D
Stock Option (Right to Buy)
19.39
2019-08-23
4
M
0
5625
0.00
D
2026-02-22
Common Stock
5625
52954
D
Shares sold pursuant to a 10b5-1 plan.
The shares were sold at prices ranging from $43.47 to $44.29. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $44.62 to $44.72. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $41.61 to $42.57. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $42.61 to $43.60. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $43.61 to $43.79. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Twenty-five percent of the shares subject to the option vested on March 1, 2017, and the remainder vest in equal amounts quarterly thereafter for the following three years.
/s/ Dorothy Pacini, Attorney-in-fact
2019-08-26